FISH for Bcl-2Sample

FISH for Bcl-2Sample

The Bcl-2 gene, short for B-cell lymphoma 2, is a gene that plays an essential role in regulating cell death by either inhibiting or inducing apoptosis (programmed cell death). The Bcl-2 protein encoded by this gene is primarily known for its function in preventing apoptosis of lymphocytes. Bcl-2 gene rearrangements can lead to an overexpression of the Bcl-2 protein, which may contribute to the progression of various types of cancer, especially non-Hodgkin lymphoma. Fluorescence In Situ Hybridization, commonly known as FISH, is a test used to detect chromosomal abnormalities, including rearrangements of the Bcl-2 gene.

  • Test NameFISH for Bcl-2Sample
  • Sample TypeBlood or Tissue
  • Preparations RequiredNo special preparation is needed for this test, but it’s important to follow any instructions given by the doctor or the laboratory.
  • Report Time7 days

What is the FISH test for Bcl-2?

TheFISH test for Bcl-2 is a specialized lab technique that utilizes fluorescent probes to detect rearrangements of the Bcl-2 gene. This can be significant in the diagnosis and management of certain types of cancer, particularly non-Hodgkin lymphoma.

How is the FISH test for Bcl-2 performed?

The test is performed on a sample of blood or tissue. Fluorescent probes specific for the Bcl-2 gene are applied to the sample, and under a fluorescence microscope, the probes will bind to the gene's location, allowing for the visualization of any abnormalities or rearrangements.

Home Sample Collection Process
Book your convenient slot
Book your convenient slot
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
Reporting of the sample at lab
Reporting of the sample at lab
Download Reports
Download Reports
Frequently Asked Questions

Bcl-2 is an oncogene that, when overexpressed due to gene rearrangement, can lead to the unchecked growth of cells, potentially resulting in cancer. The test is vital in diagnosing certain types of lymphoma, understanding their prognosis, and guiding treatment decisions.

Individuals diagnosed with or suspected of having non-Hodgkin lymphoma or other cancers in which Bcl- 2 is implicated should consider undergoing this test. It can also be recommended for individuals with a family history of such cancers.

A positive result indicates a rearrangement in the Bcl-2 gene, which can be associated with an overexpression of the Bcl-2 protein. This is often associated with certain types of non-Hodgkin lymphoma.

The results can guide treatment decisions. For instance, patients with certain Bcl-2 rearrangements might benefit from targeted therapies that inhibit the Bcl-2 protein.

The test itself is typically low-risk, involving a routine blood draw or tissue biopsy. However, as with any test, there is a small risk of infection or bleeding at the needle site.

Genetic counseling may be recommended for patients and families to understand the implications of Bcl-2 gene rearrangements, especially in cases with a genetic predisposition to cancer.

Yes, additional tests such as immunohistochemistry, flow cytometry, and other genetic tests might be performed alongside the FISH test for a more comprehensive understanding of the cancer.

It can help in the early diagnosis of certain types of lymphoma by identifying genetic changes that are characteristic of these cancers.

While lifestyle choices can impact overall cancer risk, there is limited evidence to suggest a direct impact on the Bcl-2 gene. However, maintaining a healthy lifestyle is always beneficial.

If there is a Bcl-2 gene rearrangement, it is advisable to consult an oncologist who specializes in the treatment of lymphoma and other cancers.

Yes, there are targeted therapies such as Venetoclax that specifically inhibit the Bcl-2 protein and are used in the treatment of certain cancers.

While the test is highly accurate, it is usually considered alongside other diagnostic tests and clinical information for a comprehensive evaluation.

Bcl-2 gene rearrangements are not common in the general population but are characteristic of certain types of non-Hodgkin lymphoma.

The status of the Bcl-2 gene through FISH testing can be instrumental in the diagnosis and management of certain cancers. The results of this test provide crucial information that helps healthcare professionals make informed decisions regarding treatment and management. If you or a family member are undergoing this test or have been diagnosed with a Bcl-2 gene rearrangement, it’s important to communicate with your doctor to understand the implications and available options for treatment and monitoring.

FISH for Bcl - 2
₹ 8900
Book Your Slot
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet